• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of straninfSexually Transmitted InfectionsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Sex Transm Infect. Dec 2002; 78(6): 406–412.
PMCID: PMC1758346

Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies

Abstract

Objective: Screening for Chlamydia trachomatis in the lower genital tract may contribute to the prevention of pelvic inflammatory disease in women. The purpose of this review was to critically appraise, and summarise studies of the cost effectiveness of screening for C trachomatis.

Methods: A literature search was conducted on Medline and in Health Star from 1990–2000. Keywords were C trachomatis, screening, cost effectiveness. Bibliographies of reviewed articles were also searched. The population studied was asymptomatic sexually active women under 30 years of age in a primary care setting. The intervention assessed was screening for lower genital tract infection with C trachomatis and the outcomes studied were cases of C trachomatis detected, cases of PID prevented, and associated costs. Studies were assessed using the Drummond criteria for economic evaluations. They were assessed qualitatively as they were too heterogeneous to allow quantitative analysis.

Results: 10 studies were included. All were modelled scenarios and all found screening to be more cost effective than simply testing symptomatic women, although all were based on probabilities that were assumed. Six of the studies focused on DNA based testing, three of them using urine. The models showed screening to be cost effective at prevalences of 3.1–10.0%, and cost saving (overtesting symptomatic women) at a prevalence as low as 1.1%, if age was used as a selection factor and DNA based tests were used in urine samples.

Conclusions: At the prevalence of infection expected in the target population, all studies suggest screening is cost effective. However, the assumptions used in the models have been difficult to confirm and there is a need for more data, particularly on the risk of complications in women with asymptomatic lower tract infection.

Full Text

The Full Text of this article is available as a PDF (142K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Taylor-Robinson D. Chlamydia trachomatis and sexually transmitted disease. BMJ. 1994 Jan 15;308(6922):150–151. [PMC free article] [PubMed]
  • Cates W, Jr, Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol. 1991 Jun;164(6 Pt 2):1771–1781. [PubMed]
  • Svensson L, Mårdh PA, Weström L. Infertility after acute salpingitis with special reference to Chlamydia trachomatis. Fertil Steril. 1983 Sep;40(3):322–329. [PubMed]
  • Weström L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):880–892. [PubMed]
  • Svensson LO, Mares I, Mårdh PA, Olsson SE. Screening voided urine for Chlamydia trachomatis in asymptomatic adolescent females. Acta Obstet Gynecol Scand. 1994 Jan;73(1):63–66. [PubMed]
  • Tchoudomirova K, Nuhov P, Tchapanova A. Prevalence, epidemiological and clinical correlates of genital Chlamydia trachomatis infection. J Eur Acad Dermatol Venereol. 1998 Nov;11(3):214–220. [PubMed]
  • Ripa T. Epidemiologic control of genital Chlamydia trachomatis infections. Scand J Infect Dis Suppl. 1990;69:157–167. [PubMed]
  • Gaydos CA, Howell MR, Pare B, Clark KL, Ellis DA, Hendrix RM, Gaydos JC, McKee KT, Jr, Quinn TC. Chlamydia trachomatis infections in female military recruits. N Engl J Med. 1998 Sep 10;339(11):739–744. [PubMed]
  • Paavonen J, Lehtinen M. Chlamydial pelvic inflammatory disease. Hum Reprod Update. 1996 Nov-Dec;2(6):519–529. [PubMed]
  • Egger M, Low N, Smith GD, Lindblom B, Herrmann B. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ. 1998 Jun 13;316(7147):1776–1780. [PMC free article] [PubMed]
  • Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996 May 23;334(21):1362–1366. [PubMed]
  • Buhaug H, Skjeldestad FE, Halvorsen LE, Dalen A. Should asymptomatic patients be tested for Chlamydia trachomatis in general practice? Br J Gen Pract. 1990 Apr;40(333):142–145. [PMC free article] [PubMed]
  • Humphreys JT, Henneberry JF, Rickard RS, Beebe JL. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics. Sex Transm Dis. 1992 Jan-Feb;19(1):47–53. [PubMed]
  • Sellors JW, Pickard L, Gafni A, Goldsmith CH, Jang D, Mahony JB, Chernesky MA. Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women. Arch Intern Med. 1992 Sep;152(9):1837–1844. [PubMed]
  • Genç M, Mårdh A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med. 1996 Jan 1;124(1 Pt 1):1–7. [PubMed]
  • Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsfield HH. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis. 1997 Mar;24(3):131–141. [PubMed]
  • Cohen DA, Nsuami M, Etame RB, Tropez-Sims S, Abdalian S, Farley TA, Martin DH. A school-based Chlamydia control program using DNA amplification technology. Pediatrics. 1998 Jan;101(1):E1–E1. [PubMed]
  • Paavonen J, Puolakkainen M, Paukku M, Sintonen H. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol. 1998 Aug;92(2):292–298. [PubMed]
  • Howell MR, Quinn TC, Brathwaite W, Gaydos CA. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transm Dis. 1998 Feb;25(2):108–117. [PubMed]
  • Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med. 1998 Feb 15;128(4):277–284. [PubMed]
  • Howell MR, Gaydos JC, McKee KT, Jr, Quinn TC, Gaydos CA. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. Sex Transm Dis. 1999 Oct;26(9):519–526. [PubMed]
  • Greenhalgh T. How to read a paper. Papers that tell you what things cost (economic analyses). BMJ. 1997 Sep 6;315(7108):596–599. [PMC free article] [PubMed]
  • Udvarhelyi IS, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly? Ann Intern Med. 1992 Feb 1;116(3):238–244. [PubMed]
  • Keenan SP, Massel D, Inman KJ, Sibbald WJ. A systematic review of the cost-effectiveness of noncardiac transitional care units. Chest. 1998 Jan;113(1):172–177. [PubMed]
  • Grimes DA, Atkins D. The U.S. Preventive Services Task Force: putting evidence-based medicine to work. Clin Obstet Gynecol. 1998 Jun;41(2):332–342. [PubMed]
  • Welte R, Kretzschmar M, Leidl R, van den Hoek A, Jager JC, Postma MJ. Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. Sex Transm Dis. 2000 Oct;27(9):518–529. [PubMed]
  • Lee HH, Chernesky MA, Schachter J, Burczak JD, Andrews WW, Muldoon S, Leckie G, Stamm WE. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet. 1995 Jan 28;345(8944):213–216. [PubMed]
  • McIntosh E, Donaldson C, Ryan M. Recent advances in the methods of cost-benefit analysis in healthcare. Matching the art to the science. Pharmacoeconomics. 1999 Apr;15(4):357–367. [PubMed]
  • Stephenson JM. Screening for genital chlamydial infection. Br Med Bull. 1998;54(4):891–902. [PubMed]
  • Grun L, Tassano-Smith J, Carder C, Johnson AM, Robinson A, Murray E, Stephenson J, Haines A, Copas A, Ridgway G. Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey. BMJ. 1997 Jul 26;315(7102):226–230. [PMC free article] [PubMed]
  • Kamwendo F, Forslin L, Bodin L, Danielsson D. Programmes to reduce pelvic inflammatory disease--the Swedish experience. Lancet. 1998;351 (Suppl 3):25–28. [PubMed]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...